Walsh & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.63K Buy
+25
New +$3.46K ﹤0.01% 230
2026
Q2
– Sell
-4
Closed -$481 – 274
2026
Q1
$481 Buy
+4
New +$462 ﹤0.01% 233

Other funds holding MRK

Walsh & Associates's MRK Position: Q3 2026 in Review

Walsh & Associates opened a new position in Merck (MRK) in Q3 2026: 25 shares worth $3.63K. The stake represents ﹤0.01% of the portfolio and ranks #230 among its holdings. This is a return to the name: Walsh & Associates previously reported a position in MRK as recently as Q1 2026.

Walsh & Associates first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Walsh & Associates held 25 shares of Merck worth $3.63K as of Q3 2026.
  • Merck was a new Walsh & Associates position in Q3 2026.
  • Merck made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #230 holding.
  • Walsh & Associates first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.